ICH-GCP(R3)Revision: Webinar PLUS Workshop
Learn about the latest updates and revisions to the ICH-GCP guidelines at the event! This event is organised by IFAPP!
Location
Online
Agenda
11:00 AM - 1:00 PM
ICH – GCP revision webinar
Rebecca Stanbrook
Gabriele Schwarz
Good to know
Highlights
- Online
Refund Policy
About this event
ICH-GCP(R3): Follow-up Workshop - 18 September 2025
In June 2025, participants had the opportunity to learn directly from ICH E6(R3) Expert Working Group representatives Gabriele Schwarz (BfArM, EC/EU representative) and Rebecca Stanbrook (EFPIA Topic Lead). The session provided a comprehensive overview of the extensive revision of the ICH E6 Guideline, covering its new structure, principles, and annexes. Key updates included the flexible risk-based framework, expanded expectations for investigators and sponsors, quality-by-design in trial design, and strengthened requirements around data governance, computerized systems, and essential records.
To build on this foundation, a virtual workshop will now address the practical challenges of implementing ICH-GCP(R3) in clinical trials. Through interactive discussions and case-based insights, participants will explore how to translate the revised guideline into daily operations and manage the most critical changes in practice.
Speakers
- Dr. Ingrid Klingmann, MD, PhD (PharmaTrain, Belgium)
- Elisabeth Reus (Swiss Tropical and Public Health Institute, Switzerland)
This workshop is designed for sponsors, investigators, and clinical research professionals who want to move from understanding the revision to successfully implementing it in their trials.
Frequently asked questions
The cost of €25 covers your attendance for each event date. Your attendance on ICH – GCP (R3) Webinar (30-Jun-2024 ) costs €25 and the attendance on Virtual Workshop “Practical challenges of implementing ICH-GCP(R3) in your clinical trials” (18- Sep-2025 10:30 CEST to 15:00 CEST) costs €25.
Once you make the payment, you will receive an email with the ZOOM link for each session.